News
NOTV
--
0.00%
--
DJ Inotiv, Inc. CEO Robert Leasure on Q2 2021 Results -- Earnings Call Transcript >NOTV
Dow Jones · 1d ago
We Might See A Profit From Inotiv, Inc. (NASDAQ:NOTV) Soon
With the business potentially at an important milestone, we thought we'd take a closer look at Inotiv, Inc.'s...
Simply Wall St. · 2d ago
Inotiv Q2 EPS $(0.06), Inline, Sales $18.75M Beat $16.61M Estimate
Inotiv (NASDAQ:NOTV) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 20 percent decrease over losses of $(0.05) per share from the same period last year. The company
Benzinga · 4d ago
Inotiv reports Q2 results
Inotiv (NOTV): Q2 GAAP EPS of -$0.06.Revenue of $18.75M (+17.1% Y/Y)Press Release
Seekingalpha · 4d ago
Inotiv, Inc. Announces Second Quarter Fiscal 2021 Financial Results
WEST LAFAYETTE, Ind., May 05, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today a...
GlobeNewswire · 4d ago
Inotiv, Inc. to Host Earnings Call
ACCESSWIRE · 4d ago
-- Earnings Flash (NOTV) INOTIV Reports Q2 Revenue $18.8M, vs. Street Est of $18.7M
MT Newswires · 4d ago
Earnings Scheduled For May 5, 2021
  Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.
Benzinga · 4d ago
12 Health Care Stocks Moving In Monday's Intraday Session
 
Benzinga · 6d ago
BRIEF-Inotiv, Inc. Announces Debt Financing And Completion Of Acquisitions Of Histotox Labs, Inc. And Bolder Biopath, Inc.
reuters.com · 04/30 19:56
Inotiv, Inc. Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc.
Inotiv, Inc. (NASDAQ:NOTV) (the "Company", "We", "Our" or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today announced that the Company has secured $28.0 million in ...
GlobeNewswire · 04/30 19:40
Inotiv Closes Acquisitions of HistoTox Labs, Bolder BioPATH
MT Newswires · 04/30 16:15
Inotiv, Inc. to Report Second Quarter Fiscal 2021 Financial Results and Host Conference Call on Wednesday, May 5, 2021
WEST LAFAYETTE, Ind., April 26, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, toda...
GlobeNewswire · 04/26 12:33
Inotiv, Inc. Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
WEST LAFAYETTE, Ind., April 23, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today...
GlobeNewswire · 04/23 16:15
Inotiv Closes Share Offering; Stock Climbs
MT Newswires · 04/23 13:05
Aesthetic Medical International, Acorda Therapeutics leads healthcare gainers; Atea Pharmaceuticals, Inotiv among major losers
Gainers: Aesthetic Medical International (AIH) +14%, Acorda Therapeutics (ACOR) +13%, Outlook Therapeutics (OTLK) +12%, Organovo (ONVO) +12%, Asensus Surgical (ASXC) +11%.Losers: Atea Pharmaceuticals (AVIR) -7%, Inotiv (NOTV) -7%, Lava Therapeutics (LVTX) ...
Seekingalpha · 04/21 15:01
Inotiv slides on pricing public offering
Inotiv (NOTV) prices its offering of 2,647,059 shares for $17.00/share, for gross proceeds of ~$45.0MThe offering is expected to close on April 23, 2021.Shares -7% premarket.Previously (April 20): Inotiv proposes public offering
Seekingalpha · 04/21 10:21
DJ Inotiv Offering of 2.65 Million Shares Priced at $17 Each >NOTV
Dow Jones · 04/21 10:15
BRIEF-Inotiv Inc Announces Pricing Of Public Offering Of 2,647,059 Common Shares
reuters.com · 04/21 10:09
Wall Street Sees Cautiously Lower Open, Netflix Subscriber Slowdown Dents Sentiment
MT Newswires · 04/21 09:25
Webull provides a variety of real-time NOTV stock news. You can receive the latest news about Inotiv Inc through multiple platforms. This information may help you make smarter investment decisions.
About NOTV
Inotiv, Inc, formerly Bioanalytical systems, Inc., is an international contract research company providing drug discovery and development services and analytical instruments. The Company focuses on providing drug developers with scientific research and analytical instrumentation. The Company operates in two segments: research services and research products. The research services segment provides research and development support on a contract basis directly to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. The Company supports both the non-clinical and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, but also including biotherapeutics and devices.